Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver Disease
Gut and Liver · 2025
DOI: 10.5009/gnl240295 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gut and Liver, 2025. Verfasst von Jong Ryeol Eun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea. Hauptthemen laut MEDLINE: Cilostazol, Platelet Aggregation Inhibitors, Drug Repositioning, Phosphodiesterase 3 Inhibitors. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Yonsei Liver Center, Severance Hospital, Seoul, Korea.
ORCID-Profile: Jong Ryeol Eun, Seung Up Kim
Zitieren
APA
Eun, J. R., & Kim, S. U. (2025). Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver Disease. Gut and Liver. https://doi.org/10.5009/gnl240295
Vancouver
Eun JR, Kim SU. Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver Disease. Gut and Liver. 2025. doi:10.5009/gnl240295
BibTeX
@article{Eun2025,
author = {Eun, Jong Ryeol and Kim, Seung Up},
title = {Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver Disease},
journal = {Gut and Liver},
year = {2025},
doi = {10.5009/gnl240295}
}
EUVIMED